{"id": "fmnnbi", "title": "Rapid Corona Test - Breaking News", "selftext": "The U.S. Food and Drug Administration issues the first emergency use authorization for a point-of-care Covid-19 diagnostic for the Cepheid Xpert Xpress SARS-CoV 2 test.\n\nCepheid is part of Danaher (NYSE:DHR).\n\nThe test will provide results within hours, rather than days like existing tests, said HHS Secretary Alex Azar.\n\nCepheid said the test has been designed to operate on any of its more than 23,000 automated GeneXpert\u00a0Systems worldwide, with a detection time of ~45 minutes.\n\nThe company plans to roll out the new test by March 30, the FDA said, while Cepheid said the test will begin shipping next week.\n\nIs 7am the earliest this stock can be traded?", "created_utc": 1584827640.0, "permalink": "/r/wallstreetbets/comments/fmnnbi/rapid_corona_test_breaking_news/", "is_self": true}